Table 2 Summary of the diagnostic accuracy of screening instruments and evidence sources.

From: The cost-effectiveness of risk-stratified breast cancer screening in the UK

Screening instrument

Sensitivity

Source and details of calculation

FP rate per screen

Source and details of calculation

Mammogram (MAM)

Screening sensitivity estimated using a logistic function. Maximum sensitivity assumed to be 93%.

logistic function [22] that depends on tumour diameter d (in mm), percent density m, and their interaction m/d2. The formulae is:

S(d,m)= [exp(β1 + β2d +β3 m +β4 m/d2)] / [1 + exp(β1 + β2d + β3 m +β4 m/d2)]

β1 = − 4.38

β2 = 0.49

β3 = − 1.34

β4 = − 7.18

Prevalent screen: 7.04%

Incident screens: 2.23%

NHSBSP data [25]

Automated ultrasound

47.37% relative increase applied to the sensitivity of MAM

BRAID trial detection rate of cancers with automated ultrasound compared to MAM

Prevalent screen: 7.04%

Incident screens: 2.23%

Assumed to be identical to MAM [45]

Handheld ultrasound

10.53% decrease applied to the sensitivity of AUS

Reflects the reduction in the comparative sensitivity of handheld ultrasound to automated ultrasound found in a sample of nearly 400 women [29]

Prevalent screen: 7.04%

Incident screens: 2.23%

Assumed to be identical to MAM for handheld ultrasound alone [45]

Hence, MAM combined with handheld ultrasound will have doubling of the false positive rate of MAM which is also found in a meta-analysis of studies [46]

Contrast-enhanced spectral mammogram

54.55% relative increase applied to the sensitivity of MAM

BRAID trial detection rate of cancers with contrast-enhanced spectral MAM compared to MAM

Prevalent screen: 7.14%

Incident screens: 2.59%

contrast-enhanced spectral MAM has lower specificity compared to MAM in high breast density woman of 15.92% [47]

Abbreviated MRI

61.57% relative increase applied to the sensitivity of MAM

BRAID trial detection rate of cancers with abbreviated MRI compared to MAM

Prevalent screen: 7.32%

Incident screens: 2.65%

Abbreviated MRI has lower specificity compared to MAM in high breast density woman of 18.82% [48]

Full MRI

2.22% relative increase applied to the sensitivity of AMRI

The pooled sensitivity for screening studies [30] was 0.90 for abbreviated MRI and 0.92 for full MRI

Prevalent screen: 7.60%

Incident screens: 2.75% (for combined screening of MAM with MRI)

In the only study [49] that compared MAM to MAM with supplemental MRI the addition of MRI led specificity to increase by 23.31%